text:
|What's the Switch?
|Release Date:
|October 18 2006
|Artificial Mind and Movement
|PlayStation 2
|3D, Action, Platformer
|Metacritic Score:
| 76% Critic score
76% User score
Disney's Kim Possible: What's the Switch? is the fifth video game of the Kim Possible series. It is the first Kim Possible game to appear on a home console, as all the other Kim Possible games were designed for hand-held systems.
The gameplay in What's the Switch? follows the same sidescrolling format as the predecessors. In the eleven main levels in the game, Kim is playable in all levels, Shego is playable in all but one level (Monkey Sea...), and Rufus is playable in the Great Brain Robbery, Polar Distress, and Evil Lair levels. Differing from previous games is the use of a 3D environment, which is cartoony like the show. The game switches between having the player play as Kim, Shego, and Rufus at certain areas of some levels, though Kim is the only character used in special missions.
Along the path of each level, the player has the option of collecting two kinds of tokens; Kimmunicator and Club Banana. Kimmunicator tokens unlock bonus content, and gathering all of the tokens in every level of the game unlocks Kim's mission outfit for Shego as an alternative outfit. Club Banana tokens only unlock outfits, each level having three tokens. The outfits are not unlocked linearly; each level has three tokens and if all three are collected then the appropriate outfit is unlocked. Red and green health tokens also drop to replenish each character's 5-hit health bar, and orange KP tokens grant extra lives.
Special missions take place in a 3D simulator created out of square blocks of varying types, and there are six of these missions. Access to each of these missions is gained by finding a secret mission cube in a certain level. Not all levels have these, and they are often dangerous to reach, such as being found over a reservoir of toxic fuel.
The game is also noted for having improved henchmen AI and henchmen having greater range than either Kim or Shego and much shorter times between attacks, giving players a greater challenge than enemies in the previous games. They are also of several types of henchmen besides the differentiation between Dementor and Monkey Fist's. Heavy henchmen are armored and must be left vulnerable by either an uppercut or a flying kick, jet pack henchmen can charge and are invulnerable while doing so, ranged henchmen hurl explosives, and stealth henchmen render themselves invisible until revealed by Kim's EMS. Dementor uses his regular henchmen while Monkey Fist has robotic monkey ninjas designed by Dementor. Ghost monkeys and unique model 'mini' mecha monkeys also appear in the first and last levels of the game, respectively.
There are also three multiplayer modes for those looking to play with a friend.
Kim and Shego both unlock outfits, much like Kim was able to in the game Kim Possible: Kimmunicator from 2005. They are changed at specific points in the levels, denoted by an orange light with a non-rotating Club Banana token hanging above. These outfits are strictly cosmetic and do not convey any bonus to the characters. They are consistent through cutscenes, but are reset when the game exits to the main menu. They can only be changed in the levels themselves.
Kim starts with her mission outfit, but can unlock her Bueno Nacho work outfit (Bueno Nacho), her snow gear (Downhill), an armored mission outfit (A Sitch in Time), her battle suit (So the Drama), the Centurion Project (October 31st), Sheela (Bad Boy), and Shego's outfit (The Twin Factor).
Shego begins with her standard outfit and can unlock the Supreme One outfit (A Sitch in Time), her black leather jacket plus helmet and green leather jacket (Bueno Nacho), a recolored version of Kim's battle suit, her fur jacket (Emotion Sickness), and, when all Kimmunicator tokens are collected, Kim's mission outfit.
Rufus, being a naked mole rat, does not benefit from this.
Kim Possible and Ron Stoppable arrive at Monkey Fist's castle to obtain the Mystical Monkey Idol before Dr. Drakken and Shego can get it first. However, when the two teams fight over the Idol, the power of the Idol affects Ron and Drakken, causing their minds to switch with each other's bodies. Before Kim or Shego can respond, Professor Dementor appears and steals the Idol himself.
Realizing that she needs the Idol to switch Ron and Drakken back to normal, Kim takes off in hot pursuit of Dementor. Shego, however, is also hot on his trail as the two fight through the streets and rooftops of London. In Big Ben, the two meet up again and almost begin fighting each other as Dementor escapes in his air carrier, but a call from Wade eventually have the two form an uneasy alliance to get the idol back, Kim giving Shego Ron's Kimmunicator that was given to him in the events of Team Possible. Although they succeed in getting into Dementor's air carrier, Shego leaves Kim behind and bails out as it almost crashes in his Alaskan lair, resulting in Kim being forced to stowaway on one of Dementor's trains while Shego makes her way through abandoned mines near the tracks. Wade still makes contact with Shego despite this, however, giving her advice on how to get to Dementor's lair.
Within Dementor's Alaskan Lair, it is revealed that Dementor and Monkey Fist were working together, Monkey Fist capturing Shego and escaping the lair with her while Kim disables Dementor's new Siesmic Disinhibitor (a doomsday device). Monkey Fist's double-crossing and stealing of his "greatest invention" causes Dementor to end the villainous alliance, but Kim finds her way on board the freighter Monkey Fist is on. Although she fails to keep the ship from crashing in Tokyo harbor, she does manage to rescue Shego from captivity.
In Tokyo, Monkey Fist unveils his "Mecha Monkey", powered by the Idol he had stolen, which goes on a rampage through Tokyo after splitting in half. Despite legions of robotic monkey ninjas and several wrong turns, Kim and Shego manage to get onto the Mecha Monkey and disable it, escaping with the Idol as it self-destructs (Monkey Fist being caught in the aftermath). Drakken and Ron have their brains switched back and Kim thanks Shego for the "fun and games".
Main levels:
- What's the Switch
- Idol Minds
- Great Brain Robbery
- Time's Up
- Evil Air
- Polar Distress
- Evil Lair
- Doomsday Device
- Monkey Sea...
- Monkey Doo...
- LobotoMonkey
Special mission levels:
- Special Mission 1
- Special Mission 2
- Special Mission 3
- Special Mission 4
- Special Mission 5
- Special Mission 6
Multiplayer modes
- Simian Swarm
- Monkey Mayhem
- Double Doomsday
Kim Possible
- Grappling Hook: Used for swinging over gaps, unchanged from previous games.
- Gum: Used to activate switches and to hold all but heavy and stealth henchmen in place, leaving them vulnerable to being defeated in one hit.
- Electro Magnetic Scrambler: Used to reveal hidden objects, such as platforms and stealth-using enemies. Unlike the one in So The Drama, it does nothing but disable stealth and does nothing to robotic enemies.
- Grapple Beam: This is Shego's version of Kim's grappling hook and is functionally identical, although it has a different animation.
- Magne-Go: Used to bring objects and enemies towards you. This can also be used to pull ranged henchmen towards Shego or pulling henchmen into gaps to get rid of them without having to fight them, though you will be unable to collect any tokens from them.
- EMPunch: Used to deactivate green electrical boxes and also has combat applications as it stuns enemies when used.
- A demo version of the game was featured on the demo disc in issue 111 of the Official PlayStation Magazine in December 2006. The demo includes the option to play as Kim in the Monkey Sea... level, play as Shego in the Evil Air level, and watch a preview. Although not appeared to be reviewed, the inclusion of the demo appears to show that the editors had high hopes for the game, as demo discs in the magazines have demos for games editors want for readers to keep an eye on.
- All of the show's main stars voice their respective characters, such as Christy Carlson Romano as Kim Possible, Will Friedle as Ron Stoppable, Nancy Cartwright as Rufus, Tahj Mowry as Wade, John Di Maggio as Dr. Drakken, and Nicole Sullivan as Shego.


text:
Quantum Research Associates
With our Wireless Biometric systems, we are positioned to share in the Mobile Apps and TeleHealth markets valued at $73 billion in 4 years.
- Stage Concept Only
- Industry Biotechnology
- Location Lewiston, NY, USA
- Currency USD
Company Summary
James M. AbbondanzaProfessor Emeritus
Projects managed have been funded in excess of $17 million. Owns and directs 4 integrated companies including an Internet Service Provider. Over 35 years of experience in business development and startups, strategic planning, systems design, technology R&D, marketing, manufacturing and product and technology licensing, both nationally and internationally. Consultant to NYC investment bankers in technology assessment, resulting in IPOs.

subset: commoncrawl


text:
Meru boy with 433 KCPE score appeals for school fees
Tuesday December 03 2019
A bright boy who scored 433 marks in KCPE exams risks not joining high school due to lack of fees.
Roy Koome, who attended St Ann Mission Primary School in Kariene, Meru County, said his dream of becoming a lawyer, to fight for the rights of the downtrodden, will be shattered due to his family's lack of money.
Roy said his family has lived from hand to mouth since his father was diagnosed with cancer as his treatment has been costly.
Roy's fatherJames Mworia described him as industrious and a gifted leader, given he was the school's captain.
The father of five said he was struggling to pay fees for two of his children - one in university and another in secondary school.
"I was diagnosed with cancer in 2017 and since then, most of the money I receive I use for medication, that is chemotherapy and radiation. I urge well-wishers to help us," said Mr Mworia.
Kariene Parish priest Peter Mutwiri corroborated the family's story, saying they were struggling to make ends meet.
The 13-year-old gifted footballer, however, expressed disappointment with being selected to join Friends School, Kamusinga, as his first choice was Mang'u High School.
He appealed to the government to reverse the decision so he can study at his dream school.
"I am delighted with the marks and hope I will be able to join Mang'u," he said.


text:
Saturday, November 3, 2018
cross country trip to pick up the car trailer - part 1
There was no room for error to prepare Brunnhilde for a cross country trip to pick up the Trailex open car trailer. I planned my trip to also visit my family in Toronto.
Posted by asia on my mind at 7:10 AM 2 comments:
mini love - part 46
This was the second time I remove the supercharger from Desire for inspection. Last time I remove it the power take off gear housing as bone dry without oil. Surprisingly the gears showed no sign of premature wear. I fill up the SC with GM SC oil and had since driven on track many times. To my surprise somewhat, the high pitch noise did not subside with the replenished lubricant. Fearing the PTO housing seal may be leaking and all the oil got sucked into the SC compressor housing I remove the SC for the second time to investigate.
Posted by asia on my mind at 6:04 AM No comments:
Friday, November 2, 2018
trailer prep of brunnhilde - part 6
This is one of many catch up posts, so it is foto heavy with little text. The fotos should tell most of the the story. This post pretty well wrap up the trailer preparation of the brake system for the open car Trailex tailer that I would pick up in Ohio in late August.
trailer prep of brunnhilde - part 5
energy bank for brunnhilde - part 1
I have not post for months and have a lot of catch up posts to write. I have hundreds of photos that I want blog posts to document them, for posterity.
The coach batteries in Brunnhilde has been losing capacities steadily noticeably since a couple of years ago. Recently they have gotten to the point of threatening the ability to support the DC refrigerator during an overnight stop transiting interstate highways in a trip to Iowa to pick up the open car trailer. It happen after I used the audio system quite loud for hours and then went to sleep. I estimate that must used up extra 25 Ah of energy. When I woke up I noticed the voltage had drop below 12.0 V.
Subscribe to: Posts (Atom)


text:
Public Speaking
How to become a great public speaker? Public speaking is a presentation that's given live by one person before an audience, often on stage. Despite being a useful skill in today's modern world, the average person ranks the fear of public speaking above fear of death. This list of resources is designed to help you overcome that fear and/or become a better public speaker.
A training documentary on public speaking and presentation skills.
TED Curator Chris Anderson shares the secret to a great presentation and how you can apply this knowledge.
Learn to use your voice like playing a musical instrument to increase your power and persuasiveness in any conversation or speech.
Tim Ferriss shares his preparation routine ahead of his frequent public speaking engagements.
Learn how to kick ass when you speak, present, or pitch with Bryan Kelly, as he shares insightful discussions with some of the best communicators today.
An in-depth guide answering the question "what is public speaking and why is it important?", complete with resources on how to overcome the fear of public speaking and practicing your presentation.
Share your wise thought or advice, recommend a web-page, video, podcast, ...
Almost there! Please Log in, or make a super-quick Registration.


text:
SensoLyte® 490 HIV Protease Assay Kit *Fluorimetric*
HIV protease (PR) is identified as an important drug-screening target for the design of selective acquired immunodeficiency syndrome (AIDS) therapeutics. The SensoLyte® 490 HIV Protease Assay Kit uses an optimized FRET peptide substrate for a continuous measurement of HIV protease activities. This FRET-based fluorogenic substrate is derived from a natural processing site for HIV-1 PR. Incubation of the recombinant HIV-1 PR with this substrate results in specific cleavage and a time-dependent increase in fluorescence intensity that is linearly related to the extent of substrate hydrolysis. Because of its simplicity and precision in the determination of reaction rates required for kinetic analysis, this kit offers many advantages over the commonly used HPLC or electrophoresis-based assays for peptide substrate hydrolysis by retroviral PRs. The kit contains:EDANS/DABCYL-based FRET peptide substrate (Ex/Em=340/490 nm upon cleavage), Assay buffer, HIV protease inhibitor, Fluorescence reference standard for calibration, A detailed protocol
Assays & Kits


text:
Login Block
Lost Password?
Don't have an account?
Register now!
Advanced Search
: : Iris beta 54
Posted By:
. on 2019/4/6 13:15:18
A new beta of Iris, the MorphOS IMAP E-Mail client is now available for
Improvements in the email editor; added default font (can be changed in settings)
Connected servers will periodically poll for new messages
Rewritten connection handling to improve performance and fix connection issues over time
This version also fixes:
Switching between several displayable email compontents only worked once per component due to a bug in tmp file lookup
Fixed an issue related to saving attachments from an email open in a separate window after the active folder has changed in the main window
Improved server disconnection handling
Fixed a crash in vmime related to IMAP folder access
Unread messages count could sometimes be negative due to an overflow
Fixed a long-standing reconnection problem where internal exception routing would skip over the actual reconnection routine
Fixed an OAuth2 issue which caused servers to reject authentication if they weren't used for a long time (days) so that the refresh token expired - this delegates login back to the web browser as required by OAuth2
Worked around an imap.wp.pl issue where the server returns messages in a random order instead of sorting them by uid
Fixed a Sent folder refresh issue after sending an email
Fixed a wrong UID count in folder issue causing server commands to fail after emptying a folder
Order of the Butterfly
Joined: 2010/2/10
Posts: 367
From: FRANCE
Thansk you for you hard working !
»2019/4/7 8:03
Priest of the Order of the Butterfly
Joined: 2012/11/10
Posts: 891
From: Manchester, UK/GB
Yes I agree with
- and your regular updates are inspirational. The fact that you are also working on OWB is AMAZING for us all, IMHO !! Never mind what you are doing in the "real-world" as paid employment.
I'll be sending you a donation as soon as I get a suitable amount of spare coinage to encourage you even further - if that's possible !
MacMini 1.5GHz,10,2,64MB VRAM,1GB,Airport, Bluetooth,A1016 Keyboard,T-RB22 Mouse,DVD-RW-DL+CD-RW,Iomega MiniMax,Belkin 6 port 3 x Firewire/3 x, USB2, MorphOS 3.12, Mac OSX 10.4/10.5, A1138+A1139 PwrBk MOS v3.12,Model 5,8/5,9, & PowerMac G5 2.3GHz(DP)
»2019/4/17 2:12


text:
El Paso mass shooter pleads not guilty in 22 Deaths
Patrick Crusius, the 21-year-old Texan who killed 22 people in an El Paso Walmart on Aug. 3, 2019, told police following his arrest that he was targeting "Mexicans." KTSM 9 screen grab El Paso mass shooting
Patrick Crusius, the 21-year-old Texan who killed 22 people in an El Paso Walmart on Aug. 3, 2019, told police following his arrest that he was targeting "Mexicans." KTSM 9 screen grab
El Paso mass shooting suspect Patrick Crusius, arraigned Oct. 10, 2019, has pleaded not guilty
EL PASO, Texas — The Associated Press reported that the 21-year-old man charged with capital murder in the fatal shooting of 22 people at a Walmart in El Paso, Texas, pleaded not guilty, Oct. 10, during a brief initial hearing.
Police have said Patrick Crusius of Dallas confessed to the Aug. 3 mass shooting and that he targeted Mexicans, according to the AP, and that two-dozen people survived the attack with injuries, while two remain hospitalized.
Crusius walked into the courtroom wearing a dark suit, white shirt and glasses, the AP reported. Crusius, according to the wire service was sworn in, waived the reading of his indictment and pleaded not guilty. The entire hearing lasted less than three minutes.
The AP reported some 80 members of the public crammed into the courtroom on the top floor of the El Paso County Courthouse to witness Crusius'first appearance, describing some wiping away tears as Crusius pronounced his plea.
Among the crowd was a delegation from the Mexican Consulate. Eight Mexican citizens were killed in the attack and most of the victims had Hispanic last names. Among the dead was a German citizen who lived in Ciudad Juarez, Mexico, according to the AP.
Local prosecutors have said they will seek the death penalty. Federal authorities are weighing capital murder and hate crime charges. The Department of Justice has called the shooting an act of domestic terrorism, according to the AP account.
The first judge assigned to the case recused herself because she knew one of the people killed in the attack. The lead prosecutor said his sister also was in the Walmart during the attack and that the gunman walked right by her.
Crusius fled the scene of the shooting in his car but turned himself in less than an hour later, according to police. His arrest warrant says he declared: "I'm the shooter."
In documents filed Thursday, the El Paso prosecutor notified the court that he had shared evidence with the defense on Sept. 27. That evidence includes police and FBI interviews with Crusius, data from his cellphone, records from the Dallas-area schools he attended and tens of hours of footage captured by Walmart security cameras around the time of the shooting, according to court records.
It also includes the FBI's "manifesto analysis" — a likely reference to a racist screed railing against an influx of Hispanics into the U.S. that authorities have said Crusius posted online before the shooting.
Crusius is being held without bond in an El Paso jail. He has been on suicide watch since shortly after his arrest and is separated from other prisoners.
Courthouse News Service.


text:
Secrets of tea plant revealed by science
By:Helen Briggs Botanists have unlocked the genetic secrets of the plant prized for producing tea.whose leaves are used for all...Continue Reading
Tea: Social Drink, Caffeine Fix, or Natural Medicine?
Tea has a rich history which, according to Legend, begins in 2737 BC China. The story goes that Chinese emperor...Continue Reading


text:
« PreviousContinue »
proceed on the voyage, without loss of time, as soon as the state of the ice would permit of it. Brother Kohlmeister proposed, in this view, the Esquimaux Jonathan, of Hopedale, and the brig employed to convey the annual supply of necessaries to the three settlements, was ordered to proceed first to Hopedale, partly with a view to this ncgociation. She arrived safe with Brother Kohlmeister at this place, on the 22d July, 1810. On the same day, he proposed to Jonathan the intended expedition, laid before him the whole plan, with all its difficulties and advantages, and found him immediately willing to undertake the voyage, and to forward its object by every means in his power.
This was no small sacrifice on the part of Jonathan. An Esquimaux is naturally attached to the place of his birth} and, though he spends the summer, and indeed great part of the year, necessarily, and from inclination, in roving from one place to another in quest of food; yet in winter he settles, if possible, upon his native spot, where he is esteemed and beloved. This was eminently the case with Jonathan. He was a man of superior understanding and skill, possessed of uncommon presence of mind in difficulties and dangers, and at Hopedale considered as the principal person, or chief of his nation. But he was now ready to forsake all, and to go and reside at Okkak, among strangers, having no authority or pre-eminence, and to undertake a voyage of unknown length and peril, from whence he could not-be sure of a safe or speedy return, before the ice might set in, and confine him upon an unknown shore, during the whole of a second winter. There was, however, one consideration which outweighed every other in his mind, and made him, according to his own declaration, forget all difficulties and dangers. He hoped that the proposed voyage to visit his countrymen in the north would, in time, be a means of their becoming acquainted with the gospel of Christ, and partakers of the same blessings which he now enjoyed. This made him wiK ling to accept of the call without any hesitation. Nor did he ever, during the whole voyage, forsake that generous principle, by which he was at first influenced, but his cheerful, firm, and faithful conduct proved, under all circumstances, most honourable to the character of a true convert to Christianity.
Brother Kohlmeister being, after seventeen years residence in Labrador, complete master of the Esquimaux language, and deservedly beloved and respected both by Christians and heathens, and possessing an invincible zeal to promote their temporal and spiritual welfare, was a man eminently qualified to undertake the commission, and to conciliate the affections of unknown heathen. He had also previously made himself acquainted with the use of the quadrant, and with other branches of science, useful on such an occasion.
Brother Kmoch, his companion, joined to other essential qualifications, great cheerfulness and intrepidity.
All the parties having met at Okkak, in the autumn of 1810, the winter was partly spent in preparations for the intended expedition, and Jonathan's boat put into the best possible state of repair.
Outfit. Opinions of the Esquimaux respecting the Voyage. Description of the Company. Departure from Okkak. Arrival at Nungorome.
JUNE 16, 1811. The ice began to loosen in the bay of Okkak, and to drive out to sea. On the 17th, the bay was quite cleared of it; but on the 18th, it returned, and seemed to preclude all possibility of setting out so soon as we inintended. On the 19th, however, it left us entirely.
20th. We were employed in hauling the boat to the edge of the water, and being floated by the tide, she came to anchor at six, P.M. She had been purchased by Jonathan, at Chateau-bay, and was about 45 feet long, twelve broad, and five deep, with two masts. We had furnished her with a complete deck, and divided her into three parts. The centre was our own cabin, into which all our baggage was stowed: the two other divisions were occupied by the Esquimaux. A small boat, brought from Lewis, was taken in tow.
21st. We began to ship our provision and baggage: viz. six cwt. of ship's biscuit, sixteen bushels of pease, one cwt. of salt pork and best beef, (of which but a small portion was consumed, as we were generally well supplied with fresh provisions, procured by shooting), a firkin of butter, half cwt. of captain's biscuit, one cwt. of flour, two small barrels of gunpowder, one cwt. of large and small shot, half; cwt. of tobacco, two eighteen-gallon barrels of ale, a few bottles of brandy, eighteen pounds of coffee, which was all consumed, coffee and biscuits being our usual repast; a case containing knives, wire, nails, &c. for barter, if necessary; kettles and other utensils. Besides that every man had his fowling-piece, we had four muskets in reserve. After bringing all on board, we had just room enough to sleep in our cabin.
22d, was spent in conferring with our brethren, on various subjects relating to the voyage.
23d. All the Esquimaux met at the chapel, and in the most affectionate manner, and with many tears, bid us and our company farewell. They were the more affected with grief on this occasion, as the greatest part of our own Esquimaux thought the vogage impracticable, and expected that we should all perish in doubling Cape Chudleigh, (Killinek) on account of the violence of the currents, setting round between the cape, and the many rocks and islands'which stretch from it towards the north. Reports had likewise been circulated of the hostile disposition of the Esquimaux in the Ungava bay; and it was boldly asserted, that if we even got there alive, we should never return. An old conjuror, (Angekok), Atsugarsuk, had been particularly active in spreading these reports. We cannot deny but that they occasioned some apprehension in our own minds, but being fully determined to venture in the name of God, and trusting in His protection, we were thankful that they failed to produce the intended effect on Jonathan, our guide, and on the other Esquimaux, who were to go with us, and who all remained firm.
When Jonathan was told that the Ungava Esquimaux would kill him, he generally answered: "Well, we will try, "and shall know better when we get there:" and once, conversing with us on the subject, expressed himself thus: "When I hear people talking about the danger of being "killed, I think: Jesus went to death out of love to us, "what great matter would it be, if we were to be put to "death in His service, should that be His good pleasure "concerning us."
24th. Having commended ourselves in prayer to the grace and protecting care of God our Saviour, and to the kind remembrance of our dear fellow missionaries, we set sail at two P. M.
Our company consisted of four Esquimaux families: 1. Jonathan, and his wife Sybilla, both between fifty and sixty years old. He was esteemed one of the most skilful commanders on the whole coast of Labrador, and for many years has shown himself both able and willing to serve the missionaries in a variety of ways. The boat was his own property, and we considered him as the captain of the expedition. 2. Jonas, Jonathan's son, and his wife Agnes, about thirty years of age, both intelligent, clever Esquimaux; they had their five children with them j Sophia, twelve years old, Susanna, Jonathan, Thamar, and Sybilla, the youngest but half a year old. 3. Paul, and his wife Mary, very agreeable, sensible people, about twenty years of age. Paul is Jonathan's cousin, and a man of a very warm temper. In activity and skill, he was next to Jonathan. 4. David, and his mother Rachel, the first a hopeful young man of about twenty, and the latter a good-natured old woman, who had the care of our clothes and linen, and kept them clean and in good order. Besides these four families, we took with us a boy, Okkiksuk, an orphan, about sixteen, whom Jonathan had adopted, and who promised to reward the kindness of his guardian by his good behaviour. He was always ready to render us every service in his power.
We were attended on the voyage by a skin-boat (or woman's boat) in which were Thukkekina and his wife, and their adopted child Mammak, a boy twelve years old. Their age is about forty. The skin-boat was intended as a refuge, in case of any accident happening to our own boat, and was useful in landing, as we never brought the large boat close in shore. The first four families belong to Hopedale, Thukkekina and his wife to Okkak. They considered it as a great favour conferred on them to be permitted to accompany us. Jonas and his family occupied the after-part, and the rest the fore-part of the boat. The wind was moderate, and due west. We lost sight of our habitations in about half an hour, behind the N. E. point of the island Okkak, called Sungolik.
At three, passed Cape Uivak, a cape on the continent, forming a moderately high headland, and the nearest place to Okkak, where Esquimaux spend the winter. Two or three winter-houses were standing.
The wind failing, we cast off the skin-boat, which rowed merrily a-head. Before us, between the islands to the east and the continent, we saw much drift-ice, and it required attention to avoid the large shoals, the wind coming round


text:
I first spotted this chic foyer by Anna Burke on Instagram! Anna is an alum of Kemble Interiors and currently practices interior design in New York. I love that the foyer in this East Hampton home honors its sense of place– everything feels perfect for the Hamptons! The little vignette with the gilded branch console, shell mirror, and chair upholstered in tiger velvet is such a chic moment. It sets the tone for the house as you walk in. The hexagon runner on the stairs and custom light fixture add a cool, modern touch to the space. It all feels classic and chic with an element of the unexpected thanks to the great mix Anna selected.
Have a great weekend!


text:
Victoria Dondysh, MA
Leonia NJ | 07605
About me
Victoria Dondysh was born in Moscow, Russia
The Russian pianist, Victoria Dondysh, began studying piano and composition at the age of 6. She performed her own compositions at the Central Hall of the Arts in Moscow and received honorable reviews from the major Russian newspaper. After arriving in USA she was accepted to the Juilliard School of Music on a full scholarship where she continued studying piano and composition. She was a winner at the young artist competition on Long Island where she performed Mozart's concerto No. 17 in G major, K 453. She holds her B.A and M.A. degrees from Manhattan School of Music, where she studied with Byron Janis and Arthur Balsam.
Victoria Dondysh performs throughout the USA and Europe. She appeared on public television stations and was featured on WQXR (New York classical radio station).
Ms. Dondysh has recorded 2 CD's, one of which is: Complete Bach Partitas with Centaur Records - http://www.bach-cantatas.com/NVD/BWV825-830-Dondysh.htm
Scales and arpeggios
Music theory
Preparation for piano competitions
Performance opportunities
Lesson details
In addition to standard piano repertoire and music theory, Ms. Dondysh also pays special attention to scales and arpeggios. Student preparation for piano competitions and festivals.
Education and Accreditation
B.A and M.A. degrees from Manhattan School of Music (NYC)
Monday 9am - 9pm
Tuesday 9am - 9pm
Wednesday 9am - 9pm
Thursday 9am - 9pm
Friday 9am - 9pm
Saturday N/A - N/A
Sunday N/A - N/A


text:
Map is used when you want to modify data in some list or array and return a new modified array from that original array.
I'm really enjoying cryptocurrency and all the fanfare that comes with it, so let's use an array of crypto prices in our code example.
- iterate through the array
- pull out all the prices which happen to be the second property of each currency object
- save these prices into a prices array


text:
Left of the Dial: "How Blue Can You Get?"
Written by Chris-R on February 19, 2018
Our title today is only rhetorical as you want it to be, as this weeks rendition of Left of the Dial jumps through various colour swatches until we discover which proper shading we want. Join your host Chris-R on a journey to a place where no stone is left unturned, in the breath-taking adventure of finding musical delicassantes to feast your ears upon. Our revolving door of cohosts has brought us "Dizzy" who provides a colorful commentary to enjoy. So kick back and relax, and enjoy yourself a kaleidoscopic session of Left of the Dial.
Available on Podcast form, Soundcloud, and a Spotify playlist where you can find past LotD playlists.
O, My Soul -Big Star
Power-Pop extraordinaires Big Star, who would eventually prove to be massively influential and well revered, had an insurmountable struggle to get to the pedestal they occupy today. Despite their grand grasps at fame with their (now unfortunately titled) albums Radio City and #1 Record, the band dissolved and remained penniless until further reassessment came years down the line. These hardships only prove to be further fuel to their fire, as they boast in "O, My Soul" an impassioned vocal delivery of "I can't get no license to drive my car, but I don't really need it if I'm a big star", a workingman's daydream personified. Twee guitars, and snappy elevator-esque keyboards give a candy-coated window dressing to the band that immediately produces an earworm of a tune, but provides an extra buried treasure for those who stick around to realize the further genius behind the songwriting.
Travelling Riverside Blues -Led Zeppelin
Studio albums allow the big "greats" in music to make a case for themselves; as they are fine-tuned to their pleasing and released in the format of their choosing for greatest possible effect, but the wheat is separated from the chaff when bands are forced to perform in situations beyond their control. Led Zeppelin were fortunate enough to understand that the live performance is a form of art unto itself which actualizes the true essence of the group. "Travelling Riverside Blues" in particular has a light hearted nature that is seldom seen from their back catalog, as the band is quite clearly having a field day in performing this vintage Blues track for a BBC live session. The group chose to forego their usual extravagant instrumentals in favor of light strummy guitar slide lines, and a loose vocal delivery that works wonderfully over the 12 bar blues pattern. It is clear they are having a laugh with this one, as the band isn't afraid to quote past songs in this performance; Plant reprises his eyebrow raising affinity for "lemon juice" a la The Lemon Song (or Killing Floor for any Howling Wolf listeners) or if you listen closely, Page quite clearly rips his Heartbreaker solo trills near the outro. Just a fine time all around, feel free to break out the hammock for this number.
Vitamin C -Can
For this slot in our set, it's time to open a 46 year old can of Krautrock. Fully aware of how darn odd their material is, Can takes their unique sound and runs home and beyond with it, eventually reaching an American audience. In the Krautian trend of strange humans playing in stranger robot grooves, a motorik rhythm supports the track all around which works to an almost feverish effect and provides an inherent danceability to the song. This is not even taking into account that Ege Bamyasi was self-touted as an intentional attempt to write in a more commercial manner, which worked to a surprising degree as Ege Bamyasi reaches an astounding level of acclaim from both critics and fellow musicians alike, being named as a stark influence in future sounds pursued by artists such as Sonic Youth, David Bowie, Radiohead, and Kanye West who went far enough to sample the group for his multi-platinum stadium sing-along Graduation.
Down By The Water -PJ Harvey
Dirt and grime can be found underneath this murky water, that had been built from the ground up by PJ Harvey. A gravelly low end fills the track to it's brim as other sounds playfully introduce themselves to the mix, ranging from pizzicato strings and a coy call-and-response line. PJ ends with a terrifying whisper which may be more harsh and boisterous than any loudness could have done with her, she is in complete control on this one.
Black Coffee -Beth Hart and Joe Bonamassa
The best part of waking up is Folgers in your cup, but Folgers can only go so far. What is really needed, is a scalding cup of coffee to the face which is precisely what is delivered from an unexpectedly effective collaboration between belter Beth Hart and American Blues guitarist virtuoso Joe Bonamassa. There is no time for small talk here, as Black Coffee jumps straight for the jugular, and urgency is within this songs DNA. In between Beth's frantic vocal melismas and the fact the beat runs only three measures to a bar, there is no time for rest on this one. Despite usual pitfalls of attempting Blues or Soul in a modern age, hindsight is on their side as they weave in and out of genre norms and let both of their individual personalities shine through in a wonderfully natural manner. Sporting a 2018 release date, this very well may be my favorite find of the year so far and I hope you find reasons to appreciate it as much as I do.
Nutbush City Limits –Ike & Tina Turner
Working with Phil Spector and his legendary Wall of Sound would be a career highlight for any artist imaginable, which is perfectly understandable, but what happens in the days that come after? Although it is now seen as their signature song, Ike and Tina Turner's seminal "River Deep – Mountain High" only skirted the Billboard charts which was a shock to everybody involved, given the obvious quality of the song which could be rubbing elbows with any of Phil Spector's finest. "Nutbush City Limits" however, does not seem too concerned with chart positionings (despite it giving the duo their last significant blip on the charts), and "Nutbush City Limits" almost works as a sister study to "River Deep – Mountain High" in pure sonic scope and performance by all involved. This tracks sound almost obsesses over itself and the sound in its' contemporaries music in a manner that almost predicts the music later replicated by musicians several years later, who would resurrect this Funky style of sound into something new. Traditional song structure is eschewed for almost more of a free jam atmosphere, with new instruments joining the fray as the song scoots along. Elements that may have been novelties when first recorded such as plunky fuzz bass, quirky wah guitars, which all soon became industry standards for G-Funks reassessment of this era of sound, most astonishingly the whistle pitched synth near the end of the track which just maaaaaayyyybe caught the ear of a young Dr. Dre. Who woulda thunk it.
Goddess on the Hiway -Mercury Rev
A melancholic pop song in its' most pure form, "Goddess on the Hiway" is an excersise in both restraint and release for both Mercury Rev, and brought the group back from the edge of obscurity.The evolution of Mercury Rev closely parallels that of bandleader Jonathan Donahue's former band The Flaming Lips ,who were simultaneously recording their Indie-Pop breakthrough The Soft Bulletin, bringing them to unforeseen height. A litany of problems arose for the band prior to "Goddess on the Hiway", and the band teetered on demise and likely would've broken up if not for the surprise success of this songs parent album Deserter's Songs. Mercury Rev were able to access the underlying emotion of a song with ease, often complemented with Golden-era Disney instrumentals that somehow effortlessly blend textures into something unique for the group. It was apparent for the band when simplicity should take reign of a song, best shown in simple phrases and understated chord progressions that help accent the music into something vast and sweeping.
Trouble In Mind -Nina Simone
Miss Nina Simone glides along this Jazz club standard with ease and shines a ray of light on the listener with this chipper cut from Pastel Blues. "Trouble In Mind" prances along at a delightful pace as soon as the delicate piano run starts it all off, and a steadily played rhythm allows all worry to be left behind, just as the lyrical matter suggests. Left at a brisk 2:40 runtime, lean back and leave your blues behind you with a little help from Nina.
Crazy – Live From the Basement -Gnarls Barkley
An unassuming Pop megasmash gets a radical new makeover. Gnarls Barkley is a duo as strange as it comes, comprising of current star of "The Voice" and prior Gospel and Southern Hip-Hop mogul Ceelo Green and forward-thinking production enigma Danger Mouse. Despite chart success, it should be expected that this Gnarls Barkley has a wild side to it. This version in particular was recorded for the live music television series "From the Basement" curated by Radiohead producer Nigel Godrich, which inspires artists to reinterpret their catalog is a more minimal and stripped-down imagining. Gnarls Barkley's worldwide megasmash gets a startling rearrangement that strips it down into an exciting new form, coming complete with a new chilled out and mildly uncomfortable styling that allows this rendition to stand on it's own two feet which I may actually prefer to the original.. Instrumentally sparse, Ceelo has free reign to take center stage on the mic which very well may be an inverse effect of what made the original arrangement so addictive to the radio listening masses.
Lights Out -UFO
The early inklings of the Arena Rock era produced some of the most musically conducive friendly rivalries that the industry had ever seen. It was all a game of "who can shred faster?" or "whose singer can yelp the highest?" and nobody would accept being outdone as an answer. Of course, this is best exemplified in a live setting (it was called ARENA rock, duh.) and UFO were the unsung kings of the stadium and their seminal live record Strangers in the Night was surefire to put any nay-sayers back in their respective places. UFO was also blessed with the absolute guitar monster that is Michael Schenker, who belongs on any self-respecting music fans list of "all time greats". It is clear to see why so many musician virtuosos say they got their start from staring at the stars above in UFO.
Ventilator Blues –The Rolling Stones
Sometimes as a band, you may need to focus your collective energy into a songwriting process in order to yield results, and other times you just need to put your faith in a dormant energy that exists within the band itself which is a major part of what makes the Rolling Stones such an effective tour de force after all these years. Echoing the surreal approach found on The White Album, the Stones give their interpretation on Exile on Main Street, an album that delivers itself as a scatterbrained, at times bloated, and overall GENIUS record that displays when a band broken down to its' most essential aspects can actually highlight what makes them so compelling. "Ventilator Blues" in particular is all snarl and grit, rarely executed by the group to this severity. Without any particular structure to be withheld by, the song is left open for the gang to freely jam, most notable the ripping piano solo by session musician Nicky Hopkins. If this song isn't particularly compelling to you, it is hard to imagine that Jagger and co. care too much about it, this one is just for themselves.
The Stranger -Billy Joel
Don't let the album covers have you fooled, the Billy Joel that we have all come to know and love is not who we think he is. Alas, he has actually been The Stranger all along! Just an imposter hiding behind a mask that we all recognize as a piano driven performer, in a mask not too dissimilar to each of our own attire, which makes for a wonderfully colorful metaphor for identity crises. The instrumental is exactly as suave as you'd hope from the subject matter, acting slinky and smooth until the time to strike is right. Perhaps the standout instrument of the track being Billy's distant whistling over the main motif, originally only a placeholder until a woodwind could take its spot, his producer thankfully convinced him otherwise . So while Billy is describing the plasticities you may run into in your daily life, pause for a moment and take a close look at yourself, as you probably think that he's singing about somebody else…
Uh-Oh, Love Comes To Town -Talking Heads
As this broadcast was originally run on Valentine's Day, it only seemed like common sense to end with song salivatingly sweet as "Uh-Oh, Love Comes To Town". Unusually enough for an ensemble emerging from Punk club CBGB's, Talking Heads is nothing but smiles on this song and plays this major key ditty in an astoundingly infectious manner. In other hands, it would almost appear as though these levels of saccharine would be done in a wave of sarcasm, but the band never breaks character and encourages us all to join them in the exploration of this new feeling.
Thank you to everybody who supports Left of the Dial, make sure to catch the next installment on Wednesday at 7:00!


text:
is part of the Informa Markets Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
$16 Mondays - Thursdays ($13 after 6pm)
$19 Fridays - Sundays
Free after 5pm (December 3 0nly)
*Parking prices subject to change without notice
If arriving by vehicle, you are encouraged to access Exhibition Place from Lakeshore Blvd West using Ontario Drive or Newfoundland Drive. Important note: Princes' Gates is closed to vehicular traffic.
For accessible entrance to the Enercare Centre:
Drop off at Hall D entrance or park underground and take elevators up to show floor. For more information about wheelchair accessible parking, please visit the Enercare Centre website.
Attending the Show from outside of Toronto? The GO x One Of A Kind Combo Ticket includes round-trip GO Transit fare to and from Exhibition Station and admission to the One Of A Kind Winter Show.
Package includes:
There are two routes that stop directly at the Exhibition GO Station. Please consult the schedules below for more information.
For more detailed information about train and bus routes in your area, please visit the GO Transit website.
Take the Yonge-University Line to Union Station.Take the 509 Harbourfront streetcar to Exhibition Place. Click here for more info.
Take the Bloor-Danforth Line to Bathurst Station, board the 511 Bathurst streetcar south to Exhibition Place. Click here for more info.
Take the Bloor-Danforth Line to Dufferin Station, board the 29 Dufferin bus south to Exhibition Place. Click here for more info.
Toronto Pearson Airport to downtown Toronto in 25 minutes. Trains leave every 15 minutes. Visit UPexpress.com for more details and fares.
TTC and GO Schedules are subject to change. Please visit the relevant websites to check your route before attending.


text:
Cancer Updates,
Research & Education
Cancer Type
Breast Cancer
Lung Cancer
Prostate Cancer
Gastrointestinal Cancer
More >>
Cancer Guide
Extraordinary Healer
Ovarian Cancer Heroes
MPN Heroes
Email Sign Up
Log In
Sign Up
Cancer Types
Acute Myeloid Leukemia
Anal Cancer
Bladder Cancer
Brain Cancer
Breast Cancer
Cancer of Unknown Primary
Carcinoid Cancer
Cervical Cancer
Childhood Cancers
Colorectal Cancer
Diet and Exercise
Esophageal Cancer
Financial Issues
Gallbladder Cancer
Gastric Cancer
Gastrointestinal stromal tumor
General Financial Topics
General Psychosocial Aspect Topics
Head & Neck Cancer
Kidney Cancer
Liver Cancer
Lung Cancer
Lymphoma Cancer
Mantle Cell Lymphoma
Metastatic Breast Cancer
Neuroendocrine Cancer
Non-Hodgkin Lymphoma
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Psychosocial Issues
Sexual Health
Side Effect Management
Skin Cancer
Small Lymphocytic Lymphoma (SLL)
Testicular Cancer
Thyroid Cancer
Uterine Cancer
Vulvar Cancer
Quick Links
Cure Connections
Advocacy & Research
Magazine Subscription
Share Your Story
Newsletter Sign Up
Event Coverage
Art Gallery
Award Programs
MM Heroes
GBM Heroes
MPN Heroes
Extraordinary Healer
Ovarian Cancer Heroes
Bone Health Champions
CLL Heroes
About Us
Contact Us
Privacy Policy
Terms & Conditions
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
Copyright © 2019
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.
Currently Viewing
Expert Discusses Keytruda's Future in Lung Cancer
January 19, 2017 – Allie Strickler
FDA Grants Imbruvica an Accelerated Approval for Marginal Zone Lymphoma
January 19, 2017
Genetics Can Help Determine Brain Tumor Risk
January 19, 2017 – Shannon Connelly
Fewer Men Are Being Treated for Prostate Cancer After Screening Recommendations Changed
January 19, 2017 – Allie Strickler
The Caregiver Space Reaches Caregivers of All Ages
January 18, 2017 – Brielle Urciuoli
The Oncology Community Comments on the Affordable Care Act Repeal
January 18, 2017 – Allie Casey
Wait-and-Watch May Be a Strategy for Patients With Rectal Cancer
January 18, 2017 – Allie Strickler
Predicting HPV+ Oropharyngeal Cancer Recurrence With Novel Biomarker
January 17, 2017 – Allie Strickler
Antidiabetic Agent Linked to Increased Risk of Bladder Cancer
January 17, 2017 – Allie Casey
Program Opens to Expand Patient Access to Niraparib for Ovarian Cancer
January 17, 2017 – Brielle Urciuoli
Expert Discusses Keytruda's Future in Lung Cancer
Roy Herbst, M.D., Ph.D., spoke with CURE about the future of Keytruda, and immunotherapy in general, to treat lung cancer.
BY Allie Strickler
PUBLISHED January 19, 2017
Lung cancer experts are exploring combination regimens after
single-agent Keytruda
(pembrolizumab) gained approval for both the first- and second-line setting for patients with non-small cell lung cancer (NSCLC).
"I'm very interested in my group at Yale with combinations: pembrolizumab plus the VEGF inhibitor ramucirumab (Cyramza), pembrolizumab plus a CTLA-4 inhibitor, pembrolizumab plus a targeted argent—all of that has to be looked at," said Roy Herbst, M.D., Ph.D., professor of Medicine, chief of Medical Oncology, Yale Cancer Center and Smilow Cancer Hospital.
Frontline Keytruda was approved based on the phase 3 KEYNOTE-024 trial, in which monotherapy with the PD-1 inhibitor reduced the risk of death by 40 percent and improved progression-free survival by 4.3 months compared with doublet chemotherapy for untreated patients with advanced NSCLC with PD-L1 expression on at least 50 percent of cells.
Keytruda's approval in the second-line NSCLC setting was confirmed with data from the KEYNOTE-010 trial. In the study, the median overall survival (OS) was 10.4 months with a 2-mg/kg dose of Keytruda compared with 8.5 months with docetaxel in patients with more than 1 percent PD-L1 expression. With a larger dose of Keytruda (10 mg/kg), the median OS was 12.7 months.
In an interview with
during the 2016 IASLC World Conference On Lung Cancer, Herbst discussed the KEYNOTE-010 trial, the next steps with Keytruda in NSCLC, PD-L1 testing, and managing increased toxicities with combination regimens.
Please discuss the most recent findings from the KEYNOTE-010 study that you presented.
KEYNOTE-010 was a study that resulted in the approval of Keytruda in the refractory setting, both for patients with 1 percent or more, or 50 percent or more PD-L1 staining. And of course, the biomarker at 50 percent was used for KEYNOTE-024, which resulted in the frontline approval of Keytruda. This trial [KEYNOTE-010] was presented exactly one year ago at the ESMO Singapore meeting and published in
Now we have one more year of follow-up. The last report was rather early; many of the patients hadn't completed a year, and now we have another year's worth of follow-up, and some more mature survival data. What I showed was that 30 percent more of the patients enrolled in the trial are alive at two years. That's huge—clearly better than docetaxel therapy.
Then I talked about 47 patients who had completed the full two years of therapy, or 35 doses. Ninety percent or so had response, the rest good stable disease, and there were actually three patients with complete response, and I talked about the characteristics of those patients. A few more of them had PD-L1 high staining than the others.
But really, very few of these patients have progressed. For a few who have progressed, I showed how we reinitiated therapy with some benefit in one and not the other. I think that has to be done on a case-by-case basis.
The idea, though, that you can have a durable long-term response, that's what has changed the paradigm of lung cancer. Patients benefit, they respond, they stay responding for long periods of time, and they hopefully have a good quality of life as they live with their lung cancer.
Are there any next steps following these results?
Now that Keytruda has moved to the frontline, we're looking at combinations. I'm very interested in my group at Yale with combinations: Keytruda plus VEGF inhibitor Cyramza, Keytruda plus a CTLA-4 inhibitor, Keytruda plus a targeted argent—all of that has to be looked at.
And then there's molecular characterization. At this meeting, there were talks by Kurt Schalper, M.D., Ph.D., and Scott Gettinger, M.D., who have both looked at samples of responders and nonresponders to immunotherapy to identify genetic and immunohistologic characteristics of those who respond and don't respond. Those abstracts go a long way in telling us about responders. And, if we understand why someone's not responding or becomes resistant, can we make them into a responder with more effective therapy?
Are there any concerns for heightened toxicities with these types of combinations?
I'm actually impressed that immunotherapies are better tolerated in many cases than chemotherapy, although they do have unique toxicities related to the autoimmune effect that they release the brakes on the immune system, which are there for a reason. And of course, if you use multiple drugs together, you'll have more toxicity.
First off, we have to figure out who needs more drugs than one, and if we can get away with one drug, then that's where biomarkers will come in. But many patients are going to need combinations, and in those, we'll have to be very tuned into the toxicities and manage them aggressively early on. But I believe we can do that.
At Yale, we're one of the first sites to look at Yervoy (ipilimumab) and Opdivo (nivolumab) together, or tremelimumab and durvalumab together. We've all learned about the different toxicities and side effects, and we've learned how to manage them and be aggressive early on in that management.
What are some of the remaining challenges with immunotherapy in the first-line setting, and how can they be addressed?
Immunotherapy clearly is a new paradigm in the first-line setting. Using it for patients who have PD-L1 staining of more than 50 percent, that's only about 20 percent to 25 percent of patients. The challenge is to figure out, what about the other 75 percent? Should they get a PD-L1 or PD-1 inhibitor alone? Should they get it in combination with something else? Should they get chemotherapy followed by a PD-1/PD-L1 inhibitor? All of these trials and sequences need to be studied with molecular characteristics identified from the get-go.
Be the first to discuss this article on CURE's forum. >>
Talk about this article with other patients, caregivers, and advocates in the
Lung Cancer
CURE discussion group.
Related Articles
Sign In
Email Address
Forgot Password?
Not a member?
Sign up now!
Sign Up
Email Address
First Name
Last Name
Re-type Password
Are you a member?
Please Log In


text:
BitStash is a Decentralized Open Peer to Peer Marketplace. Participants will be able to complete purchases with confidence, every transaction is placed into a secure smart contract escrow until delivery has been verified. If a user doesn't receive the product, it will be returned its STASH Tokens.
BitStash ICO began on January 7, 2018. The ICO token supply represented 64% of the total token supply, so there was a total of 23,000,000,000 STASH tokens available, for 0.0001 ETH each. The ICO funding target was 100 ETH, the funding cap was 40,000 ETH and has ended on July 31, 2018.
Token Reserve Split (36%): TBA.
BitStash ICO featured the following bonus structure.
Bonus Structure:


text:
"With these encouraging results, we look forward to advancing SPR720 into the clinic in early 2019," said
SPR720 was assessed in a series of non-clinical studies, including IND-enabling 28- and 31-day GLP toxicology studies in non-human primates and rats, respectively, and safety pharmacology studies. In vitro MIC studies demonstrated potent activity for SPR720 against prevalent NTM pathogens, including Mycobacterium avium complex and Mycobacterium abscessus. Furthermore, in vivo studies in murine models of pneumonia demonstrated favorable efficacy relative to standard-of-care comparator agents. The data suggest that SPR720 has an acceptable safety profile, encouraging target pathogen efficacy, and a wide therapeutic margin. These results, in conjunction with the recent regulatory interactions Spero has had, support the further development of SPR720. Spero plans to initiate a First-in-Human Phase 1 clinical trial of SPR720 in early 2019.
SPR720 Research Support
Research reported in this publication was supported by the
About SPR720
SPR720 represents a novel class of antibacterial agents that target enzymes essential for bacterial DNA replication. SPR720 was in-licensed from Vertex and is being developed as an oral therapy for the treatment of pulmonary non-tuberculous mycobacterial (NTM) infections. NTM are ubiquitous environmental pathogens that can cause progressive lung damage and respiratory failure, particularly in patients with compromised immune systems or underlying pulmonary disorders. Although rare, the incidence of pulmonary NTM infections is increasing worldwide. Treatment of pulmonary NTM infections requires prolonged therapy (continuing for approximately 12 to 24 months) with a combination regimen and is frequently complicated by tolerability and/or toxicity issues. Additionally, there are currently no oral antibiotics specifically approved for use to treat pulmonary NTM infections. Thus, if successfully developed, SPR720 has the potential to address an important unmet need as the first oral antibiotic approved for the treatment of this debilitating disease. Pre-clinical in vitro and in vivo studies have demonstrated potency for SPR720 against a range of bacteria that cause pulmonary NTM infections, including Mycobacterium avium complex and Mycobacterium abscessus, a highly resistant strain responsible for high mortality. Spero believes that its intellectual property portfolio for SPR720 will provide protection globally, including in
Spero's lead product candidate, SPR994, is designed to be the first oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections.
Spero also has a platform technology known as its Potentiator Platform that it believes will enable it to develop drugs that will expand the spectrum and potency of existing antibiotics, including formerly inactive antibiotics, against Gram-negative bacteria. Spero's lead product candidates generated from its Potentiator Platform are two intravenous, or IV-administered agents, SPR741 and SPR206, designed to treat MDR Gram-negative infections in the hospital setting.
Spero is also advancing SPR720, its novel oral therapy product candidate designed for the treatment of pulmonary non-tuberculous mycobacterial (NTM) infections.
For more information, visit https://sperotherapeutics.com.
Forward-Looking Statements
This press release may contain forward-looking statements. These statements include, but are not limited to, statements about the initiation, timing, progress and results of Spero's preclinical studies and clinical trials and its research and development programs, including statements regarding management's assessment of the results of the SPR720 preclinical studies and management's belief that SPR720 may demonstrate favorable clinical results and may be able to address an unmet medical need, the timing of clinical data, Spero's cash forecast and anticipated expenses, the sufficiency of its cash resources and the availability of additional non-dilutive funding from governmental agencies beyond any initially funded awards. In some cases, forward-looking statements can be identified by terms such as "may," "will," "should," "expect," "plan," "aim," "anticipate," "could," "intent," "target," "project," "contemplate," "believe," "estimate," "predict," "potential" or "continue" or the negative of these terms or other similar expressions. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including whether results obtained in the SPR720 preclinical studies will be indicative of results obtained in future clinical trials; whether SPR720 will advance through the preclinical development and clinical trial process on a timely basis, or at all; whether the results of such trials will warrant submission for approval from the U.S. Food and Drug Administration or equivalent foreign regulatory agencies; whether Spero's cash resources will be sufficient to fund its continuing operations for the periods and/or trials anticipated; and other factors discussed in the "Risk Factors" set forth in filings that we periodically make with the U.S. Securities Exchange Commission. The forward-looking statements included in this press release represent Spero's views as of the date of this press release. Spero anticipates that subsequent events and developments will cause its views to change. However, while Spero may elect to update these forward-looking statements at some point in the future, it specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing Spero's views as of any date subsequent to the date of this press release.
Spero Investor and Media Contact:
Director, Investor Relations
Source: Spero Therapeutics, Inc.


text:
|▼ Segmentazione cerebrale per applicazioni in radiologia oncologica
|▼ Modeling radiation induced normal tissue effects
|▼ Comparison of noninvasive cardiac imaging modalities in patients with myocardial infarction
|▼ Monoclonal Antibodies for therapeutic and diagnostic applications
|▼ Chemical modification of natural molecules, such as peptides and polysaccharides, to be employed as therapeutic agents as well as sensor diagnostic tools
|Complication Probability Models for Radiation-Induced Heart Valvular Dysfunction: Do Heart-Lung Interactions Play a Role? (dominio pubblico) (171 visite)
|Feasibility Study of Outpatient Monitoring by Fitness Activity Trackers in a Radiation Oncology Department (dominio pubblico) (116 visite)
|Modeling the risk of radiation-induced lung fibrosis: Irradiated heart tissue is as important as irradiated lung. (accesso riservato) (166 visite)
|Therapeutic Potential of a Novel αvβ3 Antagonist to Hamper the Aggressiveness of Mesenchymal Triple Negative Breast Cancer Sub-Type (dominio pubblico) (66 visite)
|TNBC Challenge: Oligonucleotide Aptamers for New Imaging and Therapy Modalities. (dominio pubblico) (74 visite)


text:
mobile - desktop
3 months for $50.00
News & Events:
Posted by Gunilla on May 11, 2003 at 08:11:20:
In Reply to: sick lil new beardie posted by SoCalSerenity on May 10, 2003 at 22:36:44:
:well today i had her out in the sun all day getting her uvb uva so hopefully but she wont eat like she hissed at me today right? and her mouth was open so i dropped a cricket in it and she just closed her mouth and the cricket was half sticking out and she never ate it.. she pushed her tounge out after like 15 mins and it fell out.. she holds her head up now but doesnt eat or walk and her tounge looks really big and swollen compared to the other beardie tounges..? we dont know how to make her eat and then her tounge looks funny and big and AHHHH any suggestions ?


text:
CEREC® One-Visit Dentistry
What Is CEREC?
Dentistry has truly entered the 21st century with CEREC. Also known as One Visit Dentistry, CEREC stands for Chairside Economical Restoration of Esthetic Ceramics. The CEREC system is a Computer Aided Design – Computer Assisted Manufacturing system, CAD-CAM, specifically designed to manufacture accurate dental restorations of the highest quality. CEREC allows dentists to take images without the need for impressions and placement without the need for temporary replacements.
Smile Makeover Before & After Images
CEREC Advantages
In addition to eliminating the need for temporary restorations or impressions, CEREC offers a range of advantages, from outstanding quality to being cost-effective. The benefits include the following:
- Bio-compatible ceramics
- Cost-effective
- Durable and long lasting
- Outstanding quality
- Preservation of the tooth structural integrity
- Single appointment procedure
See What Our Patients Are Saying!
"Top notch, state of the art facility with a professional and caring team who are up to date with all the newest dental technology and education. Always a positive experience and highly recommend." -Amiee
To read more patient testimonials, click here!
Smile Makeover Before & After Images
Dental Restorations From CEREC
Many dental restorations typically require one or more visit, depending on the procedure. With the CEREC system, our staff can complete dental restorations in just one visit. For fillings, we remove the decay and old filling material. Then, the individual ceramic is fit exactly. With crowns, patients do not require temporary crowns, impressions, and or a second injection.
Veneers can restore malpositioned and discolored teeth. While adjusting your tooth, we will bond a thin layer of CEREC manufactured porcelain securely to your tooth.
The CEREC System
Step 1 – First, Dr. Brown or Dr. Vaughn will examine your tooth and determine the appropriate treatment. It could be a simple filling, inlay/onlay, or full crown. This will depend on how much healthy tooth structure remains.
After your exam, we prepare your tooth for the restoration, removing tooth tissue that has decay or weakened. This preparation is just like we would do for many other restorative techniques.
Step 2 –Then, we take an optical impression of the prepared tooth. Instead of filling a tray with impression "goop" that you must bite into and hold in your mouth until it hardens, we coat your tooth with a non-toxic, tasteless powder.
After, a camera takes a digital picture of your tooth. The whole optical impression process only takes a minute or two.
Step 3 – Next, the CEREC computer helps us create the restoration for your tooth. The CEREC 3-D software takes the digital picture using a handheld scanner. The pictures convert into a 3-dimensional virtual model on the computer screen. We then use our dental expertise to design the restoration using the CEREC computer program.
Within a few minutes, the restoration design data is sent to a separate milling machine in the office. We then place a high-quality ceramic block that matches your tooth shade in the milling machine.
Step 4 – About 10 – 20 minutes later, your all-ceramic, tooth-colored restoration is complete and ready to bond to your tooth. Finally, we try the restoration in your mouth to ensure proper fit and bite. Dr. Brown or Dr. Vaughn will polish and bond the restoration to the tooth. Your tooth is restored with no "temporary" or return trip necessary.
Caring For CEREC
After the appointment patients can return their regular activities. CEREC restorations do not require any special care. However, proper oral hygiene will increase the longevity of the restored tooth. Patients may experience temporary sensitivity. This should subside but we recommend staying away from extreme temperatures for a short time.
Schedule A Consultation
Dr. Brown has been approved by Sirona and Patterson Dental as an instructor for CEREC CAD/CAM training. He regularly teaches other dentists this technique and is a national speaker for Sirona on CEREC Connect. If you would like to learn more about the CEREC system, please call (321) 372-7700 to schedule a consultation at Implant Dentistry of Florida in Melbourne, FL.